Aethlon Medical (AEMD) Income from Non-Controlling Interests (2013 - 2026)
Aethlon Medical's (AEMD) quarterly Income from Non-Controlling Interests came in at $2.0 million in Q4 2025, up 14.36% YoY from $1.8 million in Q4 2024, and up 35.58% on a QoQ basis from $1.5 million in Q3 2025.
Aethlon Medical (AEMD) Income from Non-Controlling Interests (2013 - 2026) Analysis & Trends
Aethlon Medical (AEMD) has 13 years of Income from Non-Controlling Interests data on file, last reported at $2.0 million in Q4 2025.
- Quarterly Income from Non-Controlling Interests rose 14.36% year-over-year to $2.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.0 million (up 367.55% YoY) and the FY2024 annual result came in at $799.0, down 86.99% from the prior year.
- Income from Non-Controlling Interests grew to $2.0 million in Q4 2025, from $1.5 million in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $3.8 million in Q3 2022 to a low of -$9.8 million in Q1 2024.
- A 5-year average of $653880.6 and a median of $1.8 million in 2024 frame the typical range for Income from Non-Controlling Interests.
- Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests soared 461606.67% — and 2023, when it plunged 1541304.84%.
- Tracing AEMD's Income from Non-Controlling Interests over 5 years: stood at -$2214.0 in 2021, then soared by 128815.13% to $2.8 million in 2022, then gained by 21.35% to $3.5 million in 2023, then sank by 48.88% to $1.8 million in 2024, then gained by 14.36% to $2.0 million in 2025.
- The last three Income from Non-Controlling Interests figures came in at $2.0 million (Q4 2025), $1.5 million (Q3 2025), and $1.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 900,000.00 |
| 10 | Aethlon Medical | 1.04 Mn | 1.04 Mn | - | 1.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.55 Mn |
| Dec 31, 2025 | 2.02 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | 1.77 Mn |
| Dec 31, 2024 | 1.77 Mn |
| Sep 30, 2024 | 2.80 Mn |
| Jun 30, 2024 | 2.57 Mn |
| Mar 31, 2024 | -9.78 Mn |
| Dec 31, 2023 | 3.46 Mn |
| Sep 30, 2023 | 3.04 Mn |
| Jun 30, 2023 | 3.28 Mn |
| Mar 31, 2023 | -9.56 Mn |
| Dec 31, 2022 | 2.85 Mn |
| Sep 30, 2022 | 3.81 Mn |
| Jun 30, 2022 | 2.91 Mn |
| Mar 31, 2022 | -620.00 |
| Dec 31, 2021 | -2,214.00 |
| Sep 30, 2021 | -825.00 |
| Jun 30, 2021 | -1,135.00 |
| Mar 31, 2021 | -1,604.00 |